Mike Landsittel
About Mike Landsittel
Mike Landsittel Chief Financial Officer
Mike Landsittel currently holds the position of Chief Financial Officer. With over 15 years of experience as a senior finance professional, he has a robust background in both strategic and operational finance. As CFO, Landsittel leverages his extensive expertise to drive financial decision-making and enhance organizational performance.
Mike Landsittel Education and Expertise
Mike Landsittel is a registered Certified Public Accountant (CPA) in the state of Illinois. He holds a Bachelor of Business Administration (B.B.A.) from the University of Michigan and an M.B.A. from the Tuck School of Business at Dartmouth College. His formal education and professional certifications underscore his extensive expertise in finance, strategic planning, and operational management.
Mike Landsittel Background in Finance
Mike Landsittel's career in finance spans several esteemed roles in prominent organizations. Before his tenure as Chief Financial Officer, Landsittel served as Vice President, Finance at Blueprint Medicines from February 2016 to January 2019 and as Senior Director, Finance from September 2014 to February 2016. Preceding this, he was Senior Director of Finance at Algeta US, where he directed finance and operations to support the launch of the prostate cancer drug XOFIGO (radium Ra 223 dichloride). At Infinity Pharmaceuticals, as Director of Financial Planning, he handled budgeting, forecasting, and long-range planning, among other responsibilities.
Mike Landsittel Role at Genzyme
Mike Landsittel spent nearly 10 years at Genzyme, holding various roles in business development and strategic planning. His work involved significant contributions to the company's growth and strategic initiatives. His decade-long tenure at Genzyme provided him with substantial experience in the biotechnology and pharmaceutical industries.